Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mesenchymal stem cells in disease development and therapy

Edited by
Zhipeng Han
Lixin Wei

Mesenchymal stem cells (MSCs) are emerging as a promising therapeutic approach of cell-based therapy for a wide range of autoimmune disorders and degenerative diseases due to their ability of multi-differentiation and inflammation regulation.

This Cell & Bioscience thematic series aims to provide a collection of Primary Research Articles and Reviews that will provide a valuable overview of when and how MSCs involved in the development of the disease could further our understanding of the biological function of MSCs, as well as MSCs-based new strategy for treatment diseases.

Topics to be covered include (but are not limited to):

- Role of MSCs in immune disorder diseases

- Role of MSCs in tissue regeneration

- Interplay between MSCs and inflammatory microenvironment

- Role of MSCs in tumor progress

- Current advancement on MSCs application in disease therapy

Articles must be submitted by 1st May 2020. Please indicate that you are submitting to the "Mesenchymal stem cells in disease development and therapy" article collection.

Submission instructions

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Cell & Bioscience. The complete manuscript should be submitted through the journal submission system. To ensure that you submit to the correct thematic series please select the appropriate section in the drop-down menu upon submission. In addition, indicate within your cover letter that you wish your manuscript to be considered as part of the thematic series on series title. All submissions will undergo rigorous peer review, and accepted articles will be published within the journal as a collection.

There are currently no articles in this collection.